Giorgia Guglielmi
Giorgia Guglielmi is a freelance science writer based in Basel, Switzerland. Specializing in life sciences, medicine, and the relationship between science and society, she has published numerous articles in outlets including Nature, Science, and Scientific American. She holds a PhD in biology from the European Molecular Biology Laboratory and a Master’s in Science Writing from the Massachusetts Institute of Technology. She has received recognition for her work, including the John Kendrew Award in 2020 and an ERC-funded FRONTIERS Media Fellowship in 2025. She has also led lectures and workshops on science communication at institutions such as Harvard University and the University of Zurich.
Specific strains of the gut commensal Faecalibacterium prausnitzii may help ease the cognitive difficulties associated with Alzheimer’s disease. A new study published in Cell Reports Medicine claims.
About 11% of microorganisms that colonize the infant gut persist during the first year of life, and many of them come from the infants’ mothers. A new study published in…
Medications can accumulate in gut microbes, altering the activity of bacteria and potentially reducing the effectiveness of the drugs. A new study published in Nature claims.
New therapeutic approaches that target the gut-microbiota-immune-brain axis could help to protect preterm infants from brain injury. A new study published in Cell Host & Microbe claims.
A recent study published in Current Biology highlights how microbiotas from the past could be used to monitor environmental changes and it provides an example for how policies to control…
The findings of a recent study published in Science Advances suggest that a high-salt diet modulates the gut microbiota in ways that boost tumor immunity.
The type of microbiome that repopulates the gut after antibiotics has the potential to reprogram the mammalian immune system with long-lasting effects including on longevity. A new study published in…
Chemotherapy treatment and intestinal diseases can alter the process of programmed cell death, which can lead to gastrointestinal tract's infections.
Specific changes in the gut microbiota could contribute to disruptions in brain physiology and cognitive behavior. This process leads to cognitive impairment. A new study published in Cell Host &…
The ability to transfer resistance to infection suggests that the microbiota could be harnessed for therapeutic treatments. A new study published in Cell Reports claims.
